MARKET

ODT

ODT

Odonate Therapeutics Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.630
+0.110
+7.24%
After Hours: 1.630 0 0.00% 16:00 12/06 EST
OPEN
1.500
PREV CLOSE
1.520
HIGH
1.680
LOW
1.460
VOLUME
460.40K
TURNOVER
--
52 WEEK HIGH
28.41
52 WEEK LOW
1.460
MARKET CAP
62.74M
P/E (TTM)
-0.5998
1D
5D
1M
3M
1Y
5Y
EcoR1 Capital, LLC Buys Galapagos NV, Arcus Biosciences Inc, Protagonist Therapeutics Inc, ...
GuruFocus News · 11/22 20:38
Odonate Therapeutics Insider Sold Over $2.5M In Company Stock
Aaron I Davis, Insider at Odonate Therapeutics (NASDAQ:ODT), made a large insider sell on November 19, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Davis sold 1,200,000...
Benzinga · 11/22 15:38
Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Sold $5.7 million of Shares
GuruFocus News · 11/19 10:11
As Odonate announces share repurchases, shares plummet, hit 52-week low
Shares of Odonate Therapeutics (ODT -39.5%) are down significantly today after the company said it would begin a share repurchase plan of up to 20M shares. Shares hit a 52-week
Seekingalpha · 11/17 20:16
Odonate Therapeutics returns capital to shareholders through share repurchase
Odonate Therapeutics (NASDAQ:ODT) trades 5.2% down premarket after it commenced a share repurchase plan for up to 20M shares in order to return capital to stockholders. This action is in connection with the company’s
Seekingalpha · 11/17 13:12
BRIEF-Odonate Therapeutics Announces Planned Return Of Capital To Stockholders Through Share Repurchase Plan
reuters.com · 11/17 12:49
Odonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase Plan
Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that it will commence a share repurchase plan for up to 20 million shares in order to return capital to stockholders. This action is in connection with the Company’s previously announced...
Business Wire · 11/17 12:45
Odonate Therapeutics Q3 EPS $(0.37) Up From $(0.93) YoY
Odonate Therapeutics (NASDAQ:ODT) reported quarterly losses of $(0.37) per share. This is a 60.22 percent increase over losses of $(0.93) per share from the same period last year.
Benzinga · 11/10 22:48
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ODT. Analyze the recent business situations of Odonate Therapeutics Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
100.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ODT stock price target is 4.000 with a high estimate of 4.000 and a low estimate of 4.000.
High4.000
Average4.000
Low4.000
Current 1.630
EPS
Actual
Estimate
-0.72-0.54-0.36-0.18
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 96
Institutional Holdings: 32.96M
% Owned: 85.63%
Shares Outstanding: 38.49M
TypeInstitutionsShares
Increased
12
3.32M
New
6
269.44K
Decreased
27
2.63M
Sold Out
16
939.34K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.42%
Pharmaceuticals & Medical Research
-0.51%
Key Executives
Chairman/Chief Executive Officer/Director
Kevin Tang
Chief Financial Officer
Michael Hearne
Director
Robert Rosen
Independent Director
Aaron Davis
Independent Director
Laura Douglass
Independent Director
Craig Johnson
No Data
About ODT
Odonate Therapeutics, Inc., is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent.

Webull offers kinds of Odonate Therapeutics Inc stock information, including NASDAQ:ODT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ODT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ODT stock methods without spending real money on the virtual paper trading platform.